Original news and analysis on international IP policy
The World Health Organization’s handling of the recent pandemic influenza outbreak will be examined by an independent panel of experts beginning in April. Meanwhile, new reports from the WHO are available on influenza and on intellectual property and innovation.
Finding ways to fund research and regulating medication is critical to international public health policy and intellectual property rights specialists in 2010.
Le groupe Propriété Intellectuelle de l’Organisation Mondiale pour le Commerce s’est réuni plus brièvement que prévu, le 2 mars 2010, pour discuter d’un éventuel atelier sur un amendement visant à faciliter l’accès à des médicaments génériques abordables pour les pays dépourvus d’industrie pharmaceutique, d’une nouvelle proposition de la Bolivie, et de trois questions de propriété intellectuelle qui, bien qu’anciennes, n’ont pas connu de développement significatif.
The United Nations goal of eliminating mother-to-child transmission of HIV/AIDS is within reach, the Global Fund to Fight AIDS, Tuberculosis and Malaria said in a progress report released today.
Submissions to the United States annual review of how well it says the rest of the world is protecting US intellectual property are being assessed this week, with marked changes from previous years.
A letter from the United States government answering a variety of sticky questions about the controversial Anti-Counterfeiting Trade Agreement has been released online. The 28 January letter is addressed to Senator Ron Wyden (Democrat, Oregon) from US Trade Representative Ron Kirk.
The World Trade Organization group on intellectual property rights met today and ended early, discussing a potential workshop on an amendment intended to ease access to cheaper generic medicines in countries without a pharmaceutical manufacturing sector, a new proposal from Bolivia and three separate longstanding IP issues with no major changes.
World Trade Organization members this week will hear a report on an informal meeting on an amendment to intellectual property trade rules intended to allow easier access to medicines, which some argue has had a flawed design from its inception.
Far-reaching provisions on the patenting of medicine have been inserted into a controversial free trade agreement between the European Union and Colombia and Peru.
In a mad-dash 34-hour marathon, biotechnology and pharmaceutical industry professionals met on 1-2 February in Geneva in what was intended to be a hearth of partnering opportunities. About 600 participants debated future trends and current challenges along with open innovation, global health and vaccines.